A Cost-Effective Alternative to the Abbott i-STAT: Seamaty SG1 Blood Gas&Electrolyte Analyzer

release time:2023-05-08 09:11:22

Point-of-care testing has become a vital part of healthcare delivery, especially in critical care situations. Blood gas and electrolyte analysis is an essential component of critical care, as it helps to evaluate a patient's respiratory and metabolic status. The Abbott i-STAT is a widely used blood gas analyzer that has been a popular choice for point-of-care testing in many healthcare facilities. However, the high cost of the instrument and reagents has made it difficult for many healthcare providers to adopt this technology. The Seamaty SG1 blood gas&electrolyte analyzer presents a cost-effective alternative to the Abbott i-STAT, without compromising on quality or performance.

Product Features of Seamaty SG1

The Seamaty SG1 combines microfluidic and microbiosensing technologies to enable blood gas and electrolyte testing in a mini-testing instrument. It is a handheld blood analyzer that allows blood gas testing and electrolyte testing in one device, and offers many features that make it an ideal choice for point-of-care testing. Some of the key features of the Seamaty SG1 include:

  • Lab-quality results: The Seamaty SG1 uses dual monitoring and triple calibration for each test to ensure accurate and reliable results.
  • Easy to use: The Seamaty SG1 requires just three easy steps - adding the sample, inserting the cartridge, and reading the results. It also comes with a built-in printer for real-time printing of test results.
  • Portable: Weighing only 600g, the Seamaty SG1 is easy to carry and can be used on the patient's side.
  • Long battery life: The Seamaty SG1 comes with a built-in large-capacity lithium battery that can support up to 60 cartridges testing completed.
  • Rapid results: The portable design of the Seamaty SG1 allows it to be tested anywhere, anytime, and test results are available in just 4 minutes.
  • Small sample volume: Only 100μL of whole blood is required for a single test.

Seamaty SG1 vs Abbott i-STAT

Now let's take a closer look at the Seamaty SG1 blood gas analyzer and its advantages over the Abbott i-STAT.

Firstly, the Seamaty SG1 analyzer combines microfluidic and microbiosensing technologies, which enables blood gas and electrolyte testing in a mini-testing instrument. This technology reduces the number of reagents and achieves the purpose of reducing the cost of testing, which can help hospitals achieve maximum profitability while saving patients. In contrast, the Abbott i-STAT uses a cartridge-based system that requires a significant number of reagents, making it more expensive to operate.

Secondly, the Seamaty SG1 analyzer uses disposable reagent consumables that avoid repeated loss of electrode pieces and make the test results more accurate. On the other hand, the Abbott i-STAT uses reusable cartridges that require constant calibration and maintenance, which can lead to inaccurate results and higher costs.

Thirdly, the Seamaty SG1 analyzer has a high-definition full-color large-screen operating interface and an intelligent operating system that allows operators to have a better experience. This makes it easy to use for healthcare professionals, reducing the likelihood of errors and improving efficiency. The Abbott i-STAT, on the other hand, has a smaller screen and a less intuitive interface, making it harder to operate.

Fourthly, the Seamaty SG1 analyzer is portable and weighs only 600g, making it easy to use on the patient's side. It has a built-in large-capacity lithium battery that can support 60 cartridges testing completed. In contrast, the Abbott i-STAT requires a power source and is not as portable, limiting its use in certain situations.

Finally, the Seamaty SG1 analyzer provides rapid results, with test results available in just 4 minutes. This allows healthcare professionals to make timely decisions and improves patient care. The Abbott i-STAT also provides fast results, but the Seamaty SG1 has a smaller sample volume requirement, only 100μL of whole blood is required for a single test.

Features

Seamaty SG1

Abbott i-STAT

Handheld design

Yes

Yes

Blood gas & electrolyte test

Yes

Yes

Microfluidic technology

Yes

No

Disposable reagent consumables

Yes

No

Testing Time

4 minutes

2-3 minutes

Sample Volume

100 μL

95-250 μL

Number of Parameters Tested at One Time

10

8

Calibration

Triple calibration

Dual calibration

Screen

Full-color large screen

Small screen

Cost-Effectiveness

Yes, due to microfluidic technology and disposable reagent consumables

Yes, due to reduced laboratory testing costs

Price

Affordable

Expensive

Conclusion

In conclusion, the Seamaty SG1 analyzer is a cost-effective alternative to the Abbott i-STAT, with its microfluidic and microbiosensing technologies, disposable reagent consumables, high-definition full-color large-screen operating interface, portability, and rapid results. It is an excellent choice for point-of-care and laboratories in different situations. Healthcare professionals can benefit from its easy-to-use design, accurate results, and fast turnaround time, ultimately improving patient care. If you are looking for a blood gas and electrolyte analyzer for critical care, the Seamaty SG1 is definitely worth considering.

Seamaty SG1 vs Abbott i-STAT

Prev Return Next

Related Reading

Decoding Blood Gas Analyzers(BGA): Selecting, Applications, and Top 6 Picks

2023-08-25

Discover the top 6 blood gas analyzers(BGA) for clinical labs in our comprehensive review. Learn how to choose the right analyzer and explore their vital role in patient care.

How to Choose a Suitable Biochemistry Analyzer?

2022-06-07

In medicine, biochemistry analyzers are considered one of the essential tools. They are used primarily for diagnosing and monitoring diseases, but they can also be used for other purposes such as drug testing and food analysis.

Omicron is Not Over, Covid Rapid Test Still Needed

2022-03-28

The outbreak of the Coronavirus has also led to the emergence of Coronavirus testing products. There are currently three main methods of testing for Coronavirus in the world, which are nucleic acid testing, antibody testing, and antigen testing.